HOTH

Hoth Therapeutics, Inc. HOTH

HOTH
Hoth Therapeutics, Inc. CRIS
Curis, Inc. BCTX
BriaCell Therapeutics Corp. PALI
Palisade Bio, Inc. PCSA
Processa Pharmaceuticals, Inc. ASBP
Aspire Biopharma Holdings, Inc. LEXX
Lexaria Bioscience Corp. FBLG
FibroBiologics, Inc. Common Stock PULM
Pulmatrix, Inc. DARE
Daré Bioscience, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode HOTH CRIS BCTX PALI PCSA ASBP LEXX FBLG PULM DARE
6M -12.61 % -51.61 % -72.39 % 203.16 % -46.58 % -59.52 % -35.93 % -67.25 % -66.89 % -17.80 %
YTD 35.05 % -75.24 % -90.70 % 18.28 % -84.41 % -99.16 % -75.65 % -88.15 % -70.39 % -32.61 %
1Y 36.84 % -66.56 % -89.93 % 24.29 % -85.33 % -99.16 % -76.37 % -89.79 % -63.82 % -34.24 %
3Y -66.12 % -88.83 % -98.74 % -91.85 % -99.40 % -99.16 % -76.27 % -99.19 % -31.57 % -78.47 %
5Y -97.48 % -99.33 % -98.68 % -99.94 % -99.90 % -99.16 % -87.50 % -99.19 % -90.48 % -86.20 %
10Y -99.51 % -99.63 % 5 226.92 % -100.00 % -99.56 % -99.16 % -87.50 % -99.19 % -99.71 % -99.50 %
Depuis le début -99.51 % -99.96 % 1 644.55 % -100.00 % -99.96 % -99.16 % -87.50 % -99.19 % -99.94 % -99.74 %

Dividende